biomarkers_smart_phrases
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| biomarkers_smart_phrases [2026/04/08 04:18] – gilbert | biomarkers_smart_phrases [2026/04/08 04:35] (current) – gilbert | ||
|---|---|---|---|
| Line 43: | Line 43: | ||
| ^ Biomarker ^ Assay Purpose ^ Drug(s) ^ Diagnostic Test ^ Test ID ^ | ^ Biomarker ^ Assay Purpose ^ Drug(s) ^ Diagnostic Test ^ Test ID ^ | ||
| | **pan-TRK** | Any primary | TRK inhibitors (Larotrectinib) | pan-TRK | [[PANTRK | PANTRK]] | | | **pan-TRK** | Any primary | TRK inhibitors (Larotrectinib) | pan-TRK | [[PANTRK | PANTRK]] | | ||
| - | | **PD-L1** | NSCLC stage II to IIIA | Atezolizumab as **Adjuvant** | PDL1 SP263 | [[PDL1NSCLCATEZOSP263.docx | PDL1NSCLCATEZOSP263]] | | + | | **PD-L1 |
| - | | **ALK** | NSCLC | alectinib, lorlatinib | + | |
| </ | </ | ||
| + | [[Summary List|Summary List]] | ||
biomarkers_smart_phrases.1775621881.txt.gz · Last modified: by gilbert